Endothelium-Dependent Vasodilator Effects of Peroxisome Proliferator-Activated Receptor β Agonists via the Phosphatidyl-Inositol-3 Kinase-Akt Pathway

被引:49
作者
Jimenez, Rosario [1 ]
Sanchez, Manuel [1 ]
Jose Zarzuelo, Maria [1 ]
Romero, Miguel [1 ]
Maria Quintela, Ana [1 ]
Lopez-Sepulveda, Rocio [1 ]
Galindo, Pilar [1 ]
Gomez-Guzman, Manuel [1 ]
Manuel Haro, Jose [3 ]
Zarzuelo, Antonio [1 ,2 ]
Perez-Vizcaino, Francisco [4 ,5 ]
Duarte, Juan [1 ]
机构
[1] Univ Granada, Dept Pharmacol, Sch Pharm, Granada, Spain
[2] Ciber Enfermedades Hepat & Digest, Granada, Spain
[3] Clin Hosp Granada, Gynecol Serv, Granada, Spain
[4] Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain
[5] Ciber Enfermedades Resp, Madrid, Spain
关键词
PPAR-GAMMA; CELL PROLIFERATION; IN-VITRO; DELTA; EXPRESSION; INFLAMMATION; INHIBITION; MODULATION; MECHANISMS;
D O I
10.1124/jpet.109.159806
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Peroxisome proliferator-activated receptor beta/delta (PPAR-beta) is a ligand- activated transcription factor belonging to the nuclear hormone receptor superfamily that regulates the transcription of many target genes. More recently, acute, nongenomic effects of PPAR-beta agonists have also been described. In the present study, we hypothesized that PPAR-beta agonists might exert acute nongenomic effects on vascular tone. Here, we report that the structurally unrelated PPAR-beta ligands [4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy]acetic acid (L-165041) and 4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy]acetic acid (GW0742) induced vascular relaxation in phenylephrine-precontracted endothelium-intact rat aortic rings, which was significantly inhibited by endothelial denudation or nitric-oxide synthase (NOS) inhibition with N-G-nitro-L-arginine methylester. These relaxant effects reached steady state within 15 min. The relaxation induced by L-165041 and GW0742 in aortic rings precontracted with the thromboxane A(2) analog 9,11-dideoxy-11 alpha,9 alpha-epoxymethanoprostaglandin F2 alpha (U-46619) was unaffected either by removal of extracellular cal-cium or by incubation with calcium-free solution containing the intracellular calcium chelator 1,2-bis-(o-aminophenoxy) ethane- N,N,N',N -tetraacetic acid tetra(acetoxymethyl) ester. However, the phosphatidylinositol 3-kinase (PI3K) inhibitor 2-(4-morpholinyl)- 8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY-294002) inhibited the endothelium-dependent relaxant responses induced by both PPAR-beta agonists. Blockade of PPAR-beta with 3-[[[2-methoxy-4-(phenylamino)phenyl]amino]sulfonyl]-2-thio-phenecarboxylic acid methyl ester (GSK0660) also partially inhibited these relaxant responses, although PPAR-gamma blockade with 2-chloro-5-nitro-N-phenylbenzamide (GW9662) had no effect. In human umbilical vein endothelial cells, L-165041 and GW0742 increased nitric oxide (NO) production and Akt and endothelial NOS (eNOS) phosphorylation, which were sensitive to PI3K inhibition and PPAR-beta blockade. In conclusion, the PPAR-beta agonists acutely caused vasodilatation, which was partially dependent on endothelial-derived NO. The eNOS activation is calciumindependent and seems to be related to activation of the PI3KAkt- eNOS pathway.
引用
收藏
页码:554 / 561
页数:8
相关论文
共 43 条
[1]
Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARβ [J].
Ali, Ferhana Y. ;
Davidson, Simon J. ;
Moraes, Leonardo A. ;
Traves, Suzanne L. ;
Paul-Clark, Mark ;
Bishop-Bailey, David ;
Warner, Timothy D. ;
Mitchell, Jane A. .
FASEB JOURNAL, 2006, 20 (02) :326-328
[2]
Peroxisome proliferator-activated receptor γ plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo [J].
Asakawa, M ;
Takano, H ;
Nagai, T ;
Uozumi, H ;
Hasegawa, H ;
Kubota, N ;
Saito, T ;
Masuda, Y ;
Kadowaki, T ;
Komuro, I .
CIRCULATION, 2002, 105 (10) :1240-1246
[3]
Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer [J].
Barak, Y ;
Liao, D ;
He, WM ;
Ong, ES ;
Nelson, MC ;
Olefsky, JM ;
Boland, R ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :303-308
[4]
PPARδ:: a dagger in the heart of the metabolic syndrome [J].
Barish, GD ;
Narkar, VA ;
Evans, RM .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) :590-597
[5]
PPAR-γ inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1 [J].
Benkirane, K ;
Amiri, F ;
Diep, QN ;
El Mabrouk, M ;
Schiffrin, EL .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (01) :H390-H397
[6]
Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects [J].
Berger, J ;
Leibowitz, MD ;
Doebber, TW ;
Elbrecht, A ;
Zhang, B ;
Zhou, GC ;
Biswas, C ;
Cullinan, CA ;
Hayes, NS ;
Li, Y ;
Tanen, M ;
Ventre, J ;
Wu, MS ;
Berger, GD ;
Mosley, R ;
Marquis, R ;
Santini, C ;
Sahoo, SP ;
Tolman, RL ;
Smith, RG ;
Moller, DE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6718-6725
[7]
MAPK kinases as nucleo-cytoplasmic shuttles for PPARγ [J].
Burgermeister, Elke ;
Seger, Rony .
CELL CYCLE, 2007, 6 (13) :1539-1548
[8]
Discovering the neural basis of human social anxiety: A diagnostic and therapeutic imperative [J].
Charney, DS .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (01) :1-2
[9]
Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF-κβ [J].
Chen, F ;
Wang, MC ;
O'Connor, JP ;
He, M ;
Tripathi, T ;
Harrison, LE .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 90 (04) :732-744
[10]
Signaling by Estrogens [J].
Cheskis, Boris J. ;
Greger, James G. ;
Nagpal, Sunil ;
Freedman, Leonard P. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 213 (03) :610-617